Truist Financial’s AdvisorShares Psychedelics ETF PSIL Stock Holding History

Truist Financial’s Portfolio PSIL Stock Details PSIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-8,543	Closed	-$205K	–	2983
2026 Q2	$205K	Buy	+8,543	New	+$171K	﹤0.01%	2779

Other funds holding PSIL

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $171B AUM 106.6% 1-Year Est. Return

Vigilare Wealth Management Scottsdale, Arizona $327M AUM 12.39% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Planning Strategies Lancaster, Pennsylvania $169M AUM

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

AIM

Axiom Investment Management New York $121M AUM

Truist Financial's PSIL Position: Q3 2026 in Review

Truist Financial sold out of AdvisorShares Psychedelics ETF (PSIL) in Q3 2026, closing a stake of 8,543 shares — an estimated $205K sold.

Truist Financial first reported a position in PSIL in Q2 2026 and held it in 1 quarter. The position peaked at $205K in Q2 2026. 8 funds tracked by Wall St. Rank hold PSIL as of Q3 2026.

Truist Financial reported no remaining AdvisorShares Psychedelics ETF position as of Q3 2026 after selling out during the quarter.
Truist Financial sold 8,543 AdvisorShares Psychedelics ETF shares in Q3 2026, an estimated $205K.
Truist Financial first reported a position in AdvisorShares Psychedelics ETF in Q2 2026 and held it in 1 quarter.
Truist Financial's AdvisorShares Psychedelics ETF position peaked at $205K in Q2 2026.
8 funds tracked by Wall St. Rank held AdvisorShares Psychedelics ETF as of Q3 2026.

Based on Truist Financial's 13F filing for Q3 2026, filed 30 Oct 2026.